SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-24-000076
Filing Date
2024-05-06
Accepted
2024-05-06 16:27:52
Documents
85
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-20240331.htm   iXBRL 10-Q 1161426
2 EX-10.3 AMENDED LOAN AGREEMENT plrxrestatedloanagreement-.htm EX-10.3 638709
3 EX-31.1 CEO CERTIFICATION plrx-20240331xex311.htm EX-31.1 9811
4 EX-31.2 CFO CERTIFICATION plrx-20240331xex312.htm EX-31.2 9779
5 EX-32.1 plrx-20240331xex321.htm EX-32.1 7260
  Complete submission text file 0001746473-24-000076.txt   6977776

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20240331.xsd EX-101.SCH 52426
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20240331_cal.xml EX-101.CAL 58614
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20240331_def.xml EX-101.DEF 250224
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20240331_lab.xml EX-101.LAB 604470
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20240331_pre.xml EX-101.PRE 455437
89 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20240331_htm.xml XML 620543
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 24917943
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)